[6-K] Sanofi American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

FALSE0001121404--12-316/30/20252025Q2iso4217:EURxbrli:sharesiso4217:EURxbrli:sharesxbrli:pureiso4217:USDiso4217:USDxbrli:sharessny:proceeding00011214042025-01-012025-06-3000011214042025-06-3000011214042024-12-3100011214042024-01-012024-06-300001121404ifrs-full:IssuedCapitalMember2023-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2023-12-310001121404ifrs-full:TreasurySharesMember2023-12-310001121404ifrs-full:RetainedEarningsMember2023-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-12-310001121404ifrs-full:NoncontrollingInterestsMember2023-12-3100011214042023-12-310001121404ifrs-full:RetainedEarningsMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-01-012024-06-300001121404ifrs-full:NoncontrollingInterestsMember2024-01-012024-06-300001121404ifrs-full:TreasurySharesMember2024-01-012024-06-300001121404ifrs-full:IssuedCapitalMember2024-01-012024-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2024-01-012024-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-01-012024-06-300001121404ifrs-full:IssuedCapitalMember2024-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2024-06-300001121404ifrs-full:TreasurySharesMember2024-06-300001121404ifrs-full:RetainedEarningsMember2024-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-06-300001121404ifrs-full:NoncontrollingInterestsMember2024-06-3000011214042024-06-300001121404ifrs-full:RetainedEarningsMember2024-07-012024-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-07-012024-12-310001121404ifrs-full:NoncontrollingInterestsMember2024-07-012024-12-3100011214042024-07-012024-12-310001121404ifrs-full:TreasurySharesMember2024-07-012024-12-310001121404ifrs-full:IssuedCapitalMember2024-07-012024-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2024-07-012024-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-07-012024-12-310001121404ifrs-full:IssuedCapitalMember2024-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2024-12-310001121404ifrs-full:TreasurySharesMember2024-12-310001121404ifrs-full:RetainedEarningsMember2024-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2024-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2024-12-310001121404ifrs-full:NoncontrollingInterestsMember2024-12-310001121404ifrs-full:RetainedEarningsMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2025-01-012025-06-300001121404ifrs-full:NoncontrollingInterestsMember2025-01-012025-06-300001121404ifrs-full:TreasurySharesMember2025-01-012025-06-300001121404ifrs-full:IssuedCapitalMember2025-01-012025-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2025-01-012025-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2025-01-012025-06-300001121404ifrs-full:IssuedCapitalMember2025-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2025-06-300001121404ifrs-full:TreasurySharesMember2025-06-300001121404ifrs-full:RetainedEarningsMember2025-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2025-06-300001121404ifrs-full:NoncontrollingInterestsMember2025-06-300001121404sny:OpellaMember2025-06-300001121404sny:CommercialPaperProgramInUSAMember2025-01-012025-06-300001121404sny:CommercialPaperProgramInUSAMember2024-01-012024-06-300001121404country:AR2025-06-300001121404country:TR2025-06-300001121404sny:OpellaBusinessMember2025-04-012025-04-300001121404sny:OpellaBusinessMember2025-04-300001121404sny:OpellaMember2025-01-012025-06-300001121404sny:AssetsAcquisitionMember2025-05-270001121404sny:AssetsAcquisitionMember2025-05-272025-05-270001121404sny:VigilNeuroscienceIncMember2025-05-222025-05-220001121404sny:VigilNeuroscienceIncMember2025-05-220001121404sny:BlueprintMedicinesCorporationMember2025-06-0200011214042024-01-012024-12-310001121404sny:BiopharmaSegmentMember2025-01-012025-06-300001121404sny:BiopharmaSegmentMember2024-01-012024-12-310001121404sny:ManufacturingAndSupplyMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404sny:ManufacturingAndSupplyMembersny:BiopharmaSegmentMember2024-01-012024-12-310001121404sny:OpellaMember2025-01-012025-06-300001121404sny:OpellaMember2024-01-012024-12-310001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2024-12-310001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2024-12-310001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-12-310001121404ifrs-full:GrossCarryingAmountMember2024-12-310001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2025-01-012025-06-300001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2025-01-012025-06-300001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2025-01-012025-06-300001121404ifrs-full:GrossCarryingAmountMember2025-01-012025-06-300001121404ifrs-full:GrossCarryingAmountMembersny:AcquiredResearchAndDevelopmentMember2025-06-300001121404ifrs-full:GrossCarryingAmountMembersny:ProductsTrademarksAndOtherRightsMember2025-06-300001121404ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2025-06-300001121404ifrs-full:GrossCarryingAmountMember2025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:AcquiredResearchAndDevelopmentMember2024-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:ProductsTrademarksAndOtherRightsMember2024-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ComputerSoftwareMember2024-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2024-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:AcquiredResearchAndDevelopmentMember2025-01-012025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:ProductsTrademarksAndOtherRightsMember2025-01-012025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ComputerSoftwareMember2025-01-012025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2025-01-012025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:AcquiredResearchAndDevelopmentMember2025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembersny:ProductsTrademarksAndOtherRightsMember2025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ComputerSoftwareMember2025-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2025-06-300001121404sny:AcquiredResearchAndDevelopmentMember2024-12-310001121404sny:ProductsTrademarksAndOtherRightsMember2024-12-310001121404ifrs-full:ComputerSoftwareMember2024-12-310001121404sny:MarketedProductsMember2025-06-300001121404sny:MarketedProductsMember2024-12-310001121404sny:MarketedProductsMember2025-01-012025-06-300001121404sny:TechnologicalPlatformsMember2025-06-300001121404sny:TechnologicalPlatformsMember2024-12-310001121404sny:TechnologicalPlatformsMember2025-01-012025-06-300001121404ifrs-full:OtherIntangibleAssetsMember2025-01-012025-06-300001121404sny:OpellaMember2025-01-012025-06-300001121404sny:OpellaMember2025-06-300001121404sny:OpellaMember2024-12-310001121404sny:EuroapiMember2025-01-012025-06-300001121404sny:EuroapiMember2025-06-300001121404sny:EuroapiMember2024-12-310001121404sny:InfraservGmbhAndCoHochstKGMember2025-01-012025-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2025-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2024-12-310001121404sny:MSPVaccineCompanyMember2025-01-012025-06-300001121404sny:MSPVaccineCompanyMember2025-06-300001121404sny:MSPVaccineCompanyMember2024-12-310001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2025-01-012025-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2025-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2024-12-310001121404sny:EuroapiMember2025-06-300001121404sny:EuroapiMember2024-12-310001121404sny:MCMVaccineBVMembersny:MSPVaccineCompanyMember2025-01-012025-06-3000011214042025-05-012025-06-300001121404sny:AssociatesAndJointVenturesMember2025-01-012025-06-300001121404sny:AssociatesAndJointVenturesMember2024-01-012024-06-300001121404sny:AssociatesAndJointVenturesMember2025-06-300001121404sny:AssociatesAndJointVenturesMember2024-12-3100011214042024-10-310001121404ifrs-full:TradingEquitySecuritiesMember2025-06-300001121404ifrs-full:TradingEquitySecuritiesMember2024-12-310001121404ifrs-full:DebtSecuritiesMember2025-06-300001121404ifrs-full:DebtSecuritiesMember2024-12-310001121404ifrs-full:AllowanceForCreditLossesMember2025-06-300001121404ifrs-full:AllowanceForCreditLossesMember2024-12-310001121404ifrs-full:NotLaterThanOneMonthMember2025-06-300001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2025-06-300001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2025-06-300001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2025-06-300001121404ifrs-full:LaterThanOneYearMember2025-06-300001121404ifrs-full:NotLaterThanOneMonthMember2024-12-310001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2024-12-310001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2024-12-310001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2024-12-310001121404ifrs-full:LaterThanOneYearMember2024-12-310001121404ifrs-full:IssuedCapitalMembersny:SanofiMember2025-01-012025-06-300001121404sny:ShareRepurchase2024ProgramMember2024-04-302024-04-300001121404sny:ShareRepurchase2024ProgramMember2025-01-012025-06-300001121404sny:ShareRepurchase2025ProgramMember2025-01-292025-01-290001121404sny:ShareRepurchase2025ProgramMember2025-01-012025-06-300001121404sny:ShareRepurchase2025ProgramMember2025-02-022025-02-020001121404sny:ShareRepurchase2024ProgramMember2025-04-302025-04-300001121404sny:RestrictedSharePlan2024Member2025-01-012025-06-300001121404sny:RestrictedSharePlan2025Member2025-01-012025-06-300001121404sny:WithoutMarketConditionMembersny:RestrictedSharePlan2025Member2025-01-012025-06-300001121404sny:WithMarketConditionMembersny:RestrictedSharePlan2025Member2025-01-012025-06-300001121404sny:WithMarketConditionMembersny:ExcludingChiefExecutiveOfficerMembersny:RestrictedSharePlan2025Member2025-01-012025-06-300001121404sny:WithMarketConditionMembersrt:ChiefExecutiveOfficerMembersny:RestrictedSharePlan2025Member2025-01-012025-06-300001121404sny:RestrictedSharesMember2025-01-012025-06-300001121404sny:RestrictedSharesMember2024-01-012024-06-300001121404sny:RestrictedSharesMember2025-06-300001121404sny:RestrictedSharesMember2024-06-300001121404sny:RestrictedSharePlan2025Member2025-06-300001121404sny:RestrictedSharePlan2025Member2024-06-300001121404sny:RestrictedSharePlan2024Member2025-06-300001121404sny:RestrictedSharePlan2024Member2024-06-300001121404sny:RestrictedSharePlan2023Member2025-06-300001121404sny:RestrictedSharePlan2023Member2024-06-300001121404sny:RestrictedSharePlan2022Member2025-06-300001121404sny:RestrictedSharePlan2022Member2024-06-300001121404sny:RestrictedSharePlan2021Member2025-06-300001121404sny:RestrictedSharePlan2021Member2024-06-300001121404sny:EmployeeShareOwnershipPlanMember2025-01-290001121404sny:EmployeeShareOwnershipPlanMember2025-06-300001121404sny:EmployeeShareOwnershipPlanMember2025-01-012025-06-300001121404sny:EmployeeShareOwnershipPlanMember2024-01-310001121404sny:EmployeeShareOwnershipPlanMember2024-06-240001121404sny:EmployeeShareOwnershipPlanMember2024-01-012024-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeTwoMember2025-06-300001121404sny:StockOptionPlanMemberifrs-full:TopOfRangeMembersny:ExercisePriceRangeTwoMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2025-01-012025-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeThreeMember2025-06-300001121404sny:StockOptionPlanMemberifrs-full:TopOfRangeMembersny:ExercisePriceRangeThreeMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2025-01-012025-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeFourMember2025-06-300001121404sny:StockOptionPlanMemberifrs-full:TopOfRangeMembersny:ExercisePriceRangeFourMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2025-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2025-01-012025-06-300001121404sny:StockOptionPlanMember2025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:DebtInstrumentsMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:DebtInstrumentsMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2024-01-012024-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ForeignCurrencyTranslationMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2025-01-012025-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMembersny:ForeignCurrencyTranslationMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMember2024-01-012024-12-310001121404sny:AmortizedCostNettingMember2025-06-300001121404sny:AdjustmentToDebtMeasuredAtFairValueMember2025-06-300001121404sny:ValueOnRedemptionMember2025-06-300001121404sny:ValueOnRedemptionMember2024-12-310001121404sny:NonCurrentLiabilitiesMembersny:ValueOnRedemptionMember2025-06-300001121404sny:CurrentLiabilitiesMembersny:ValueOnRedemptionMember2025-06-300001121404sny:NonCurrentLiabilitiesMembersny:ValueOnRedemptionMember2024-12-310001121404sny:CurrentLiabilitiesMembersny:ValueOnRedemptionMember2024-12-310001121404sny:NonCurrentAssetsMembersny:ValueOnRedemptionMember2025-06-300001121404sny:CurrentAssetsMembersny:ValueOnRedemptionMember2025-06-300001121404sny:NonCurrentAssetsMembersny:ValueOnRedemptionMember2024-12-310001121404sny:CurrentAssetsMembersny:ValueOnRedemptionMember2024-12-310001121404sny:CurrentLiabilitiesMembersny:CommercialPaperProgramInUSAMembersny:ValueOnRedemptionMember2025-06-300001121404sny:CurrentLiabilitiesMembersny:CommercialPaperProgramInFranceMembersny:ValueOnRedemptionMember2025-06-300001121404sny:OneBillionFiveHundredMillionBondsIssuedInMarch2025Member2025-06-300001121404sny:FixedRateBondMaturingMarch2027Member2025-06-300001121404sny:FixedRateBondMaturingMarch2031Member2025-06-300001121404sny:OneBillionFiveHundredMillionBondsIssuedInJune2025Member2025-06-300001121404sny:FixedRateBondMaturingJune2029Member2025-06-300001121404sny:FixedRateBondMaturingMarch2032Member2025-06-300001121404sny:FixedRateBondIssueFromApril2020Member2025-06-300001121404sny:FixedRateBondIssueFromApril2022Member2025-06-300001121404sny:FourBillionFacilityMaturingDecember2027Membersny:SanofiEuroMediumTermNotesMember2025-06-300001121404sny:FourBillionFacilityMaturingMarch2030Membersny:SanofiEuroMediumTermNotesMember2025-06-300001121404sny:CommercialPaperProgramInFranceMembersny:SanofiEuroMediumTermNotesMember2025-06-300001121404sny:CommercialPaperProgramInUSAMembersny:SanofiEuroMediumTermNotesMember2025-06-300001121404sny:CommercialPaperProgramInUSAMembersny:SanofiEuroMediumTermNotesMember2025-01-012025-06-300001121404sny:CommercialPaperProgramInFranceMembersny:SanofiEuroMediumTermNotesMember2025-01-012025-06-300001121404sny:AtMarketValueMember2025-06-300001121404sny:AtMarketValueMember2024-12-310001121404sny:ValueOnRedemptionMember2025-01-012025-06-300001121404sny:ValueOnRedemptionMember2024-01-012024-12-310001121404sny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencySalesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencySalesInChineseYuanRenminbiMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInChineseYuanRenminbiMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInRussianRoubleMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInJapaneseYenMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInJapaneseYenMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencySalesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencySalesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInRussianRoubleMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInRussianRoubleMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInRussianRoubleMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesInTurkishLiraMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesInTurkishLiraMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInTurkishLiraMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInTurkishLiraMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInTurkishLiraMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInTurkishLiraMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInTurkishLiraMemberifrs-full:AtFairValueMember2025-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInCanadianDollarMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInCanadianDollarMemberifrs-full:AtFairValueMember2025-06-300001121404sny:AtNotionalAmountMember2025-06-300001121404ifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2025-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2025-06-300001121404sny:CrossCurrencySellerSwapsMembersny:AtNotionalAmountMember2025-06-300001121404sny:CrossCurrencySellerSwapsMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:CrossCurrencySellerSwapsInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:CrossCurrencySellerSwapsInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencySalesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencySalesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencySalesInChineseYuanRenminbiMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencySalesInChineseYuanRenminbiMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencySalesInCanadianDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencySalesInCanadianDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInHungarianFlorintMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInHungarianFlorintMemberifrs-full:AtFairValueMember2025-06-300001121404sny:CrossCurrencySwapExpiring2029Member2025-06-300001121404sny:CrossCurrencySwapExpiring2032Member2025-06-300001121404sny:CrossCurrencySwapMember2025-06-300001121404sny:CrossCurrencySwapMember2025-01-012025-06-300001121404sny:ForwardCurrencySalesInUSDollarMember2025-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2025-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2025-01-012025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1.02Membersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Membersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Member2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:AtFairValueMember2025-06-300001121404ifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:ValueOfHedgeRecognizedInEquityMember2025-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:FairValueHedgesMembersny:AtNotionalAmountMember2025-06-300001121404ifrs-full:FairValueHedgesMemberifrs-full:AtFairValueMember2025-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2024-12-310001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2024-12-310001121404sny:OtherLiabilities1Member2024-12-310001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2025-01-012025-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2025-01-012025-06-300001121404sny:OtherLiabilities1Member2025-01-012025-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2025-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2025-06-300001121404sny:OtherLiabilities1Member2025-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:SwedishOrphanBiovitrumABMember2025-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:SwedishOrphanBiovitrumABMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2025-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:SwedishOrphanBiovitrumABMemberifrs-full:LaterThanFiveYearsMember2025-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2024-12-310001121404sny:ProvisionsForOtherLongTermBenefitsMember2024-12-310001121404sny:NonCurrentRestructuringProvisionMember2024-12-310001121404ifrs-full:MiscellaneousOtherProvisionsMember2024-12-310001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2025-01-012025-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2025-01-012025-06-300001121404sny:NonCurrentRestructuringProvisionMember2025-01-012025-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2025-01-012025-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2025-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2025-06-300001121404sny:NonCurrentRestructuringProvisionMember2025-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2025-06-300001121404ifrs-full:PlanAssetsMembercountry:GB2025-06-300001121404ifrs-full:PlanAssetsMembersny:PensionsAndOtherPostEmploymentBenefitsMember2025-01-012025-06-300001121404ifrs-full:PlanAssetsMembersny:PensionsAndOtherPostEmploymentBenefitsMember2024-01-012024-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2025-01-012025-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2024-01-012024-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MinimumMember2025-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MaximumMember2025-06-300001121404ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMembersny:UKZONEMember2025-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MinimumMember2024-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MaximumMember2024-06-300001121404ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMembersny:EUROZONEMember2024-06-300001121404sny:OpellaBusinessMembersny:PensionsAndOtherPostEmploymentBenefitsMember2025-01-012025-06-300001121404sny:OpellaBusinessMembersny:PensionsAndOtherPostEmploymentBenefitsMember2024-01-012024-06-300001121404sny:ActionForWhichWeAreDefendantMembersny:GoldBondProductLitigationInTheUSMembersny:ProductLiabilitiesMember2025-06-300001121404sny:ActionForWhichSanofiAreDefendantMembersny:PlavixAttorneyGeneralActionInHawaiiMember2025-05-012025-05-310001121404sny:OtherOperatingIncomeExpenseMemberifrs-full:OtherRelatedPartiesMember2025-01-012025-06-300001121404sny:OtherOperatingIncomeExpenseMemberifrs-full:OtherRelatedPartiesMember2024-01-012024-06-300001121404sny:OtherOperatingIncomeExpenseMembersny:RegeneronMember2025-01-012025-06-300001121404sny:OtherOperatingIncomeExpenseMembersny:RegeneronMember2024-01-012024-06-300001121404sny:CommercializationRelatedExpensesMemberifrs-full:OtherRelatedPartiesMembersny:RegeneronMember2025-01-012025-06-300001121404sny:CommercializationRelatedExpensesMemberifrs-full:OtherRelatedPartiesMembersny:RegeneronMember2024-01-012024-06-300001121404sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMembersny:AntibodiesAllianceMember2025-01-012025-06-300001121404sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMembersny:AntibodiesAllianceMember2024-01-012024-06-300001121404sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMembersny:AntibodiesAllianceMember2025-01-012025-06-300001121404sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMembersny:AntibodiesAllianceMember2024-01-012024-06-300001121404sny:CommercializationRelatedExpensesMembersny:AntibodiesAllianceMember2025-01-012025-06-300001121404sny:CommercializationRelatedExpensesMembersny:AntibodiesAllianceMember2024-01-012024-06-300001121404sny:AntibodiesAllianceMember2025-01-012025-06-300001121404sny:AntibodiesAllianceMember2024-01-012024-06-300001121404sny:OthersCounterpartyMember2025-01-012025-06-300001121404sny:OthersCounterpartyMember2024-01-012024-06-3000011214042022-07-012023-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2025-01-012025-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:DupixentMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:DupixentMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:DupixentMember2025-01-012025-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:DupixentMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:DupixentMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:DupixentMember2024-01-012024-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AltuviiioMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:AltuviiioMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AltuviiioMember2025-01-012025-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AltuviiioMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:AltuviiioMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AltuviiioMember2024-01-012024-06-300001121404sny:AltuviiioMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:NexviazymeMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:NexviazymeMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:NexviazymeMember2025-01-012025-06-300001121404sny:NexviazymeMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:NexviazymeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:NexviazymeMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:NexviazymeMember2024-01-012024-06-300001121404sny:NexviazymeMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:CabliviMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:CabliviMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:CabliviMember2025-01-012025-06-300001121404sny:CabliviMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:CabliviMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:CabliviMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:CabliviMember2024-01-012024-06-300001121404sny:CabliviMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:XenpozymeMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:XenpozymeMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:XenpozymeMember2025-01-012025-06-300001121404sny:XenpozymeMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:XenpozymeMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:XenpozymeMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:XenpozymeMember2024-01-012024-06-300001121404sny:XenpozymeMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AubagioMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:AubagioMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AubagioMember2025-01-012025-06-300001121404sny:AubagioMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AubagioMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:AubagioMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AubagioMember2024-01-012024-06-300001121404sny:AubagioMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:SarclisaMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:SarclisaMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:SarclisaMember2025-01-012025-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:SarclisaMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:SarclisaMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:SarclisaMember2024-01-012024-06-300001121404sny:SarclisaMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:RezurockMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:RezurockMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:RezurockMember2025-01-012025-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:RezurockMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:RezurockMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:RezurockMember2024-01-012024-06-300001121404sny:RezurockMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:TzieldMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:TzieldMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:TzieldMember2025-01-012025-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:TzieldMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:TzieldMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:TzieldMember2024-01-012024-06-300001121404sny:TzieldMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:OtherProductsSegmentMembersny:IndustrialSalesMember2025-01-012025-06-300001121404country:USsny:OtherProductsSegmentMembersny:IndustrialSalesMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:OtherProductsSegmentMembersny:IndustrialSalesMember2025-01-012025-06-300001121404sny:IndustrialSalesMembersny:OtherProductsSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:OtherProductsSegmentMembersny:IndustrialSalesMember2024-01-012024-06-300001121404country:USsny:OtherProductsSegmentMembersny:IndustrialSalesMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:OtherProductsSegmentMembersny:IndustrialSalesMember2024-01-012024-06-300001121404sny:IndustrialSalesMembersny:OtherProductsSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2025-01-012025-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:PolioPertussisHibVaccinesMember2024-01-012024-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2025-01-012025-06-300001121404sny:MeningitisTravelAndEndemicVaccinesMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:MeningitisTravelAndEndemicVaccinesMember2024-01-012024-06-300001121404sny:MeningitisTravelAndEndemicVaccinesMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:RSVVaccinesMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:RSVVaccinesMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:RSVVaccinesMember2025-01-012025-06-300001121404sny:RSVVaccinesMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:RSVVaccinesMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:RSVVaccinesMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:RSVVaccinesMember2024-01-012024-06-300001121404sny:RSVVaccinesMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2025-01-012025-06-300001121404country:USsny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2025-01-012025-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2025-01-012025-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2025-01-012025-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404country:USsny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:InfluenzaVaccinesMember2024-01-012024-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2024-01-012024-06-300001121404srt:EuropeMember2025-01-012025-06-300001121404country:US2025-01-012025-06-300001121404sny:OtherCountriesMember2025-01-012025-06-300001121404srt:EuropeMember2024-01-012024-06-300001121404country:US2024-01-012024-06-300001121404sny:OtherCountriesMember2024-01-012024-06-300001121404sny:OpellaBusinessMember2025-01-012025-06-300001121404sny:OpellaBusinessMember2024-01-012024-06-300001121404ifrs-full:AllOtherSegmentsMember2025-01-012025-06-300001121404ifrs-full:ReportableSegmentsMember2025-01-012025-06-300001121404ifrs-full:AllOtherSegmentsMember2024-01-012024-06-300001121404ifrs-full:ReportableSegmentsMember2024-01-012024-06-300001121404ifrs-full:OperatingSegmentsMember2025-01-012025-06-300001121404ifrs-full:OperatingSegmentsMember2024-01-012024-06-300001121404ifrs-full:MaterialReconcilingItemsMember2025-01-012025-06-300001121404ifrs-full:MaterialReconcilingItemsMember2024-01-012024-06-300001121404sny:BiopharmaSegmentMember2025-06-300001121404sny:BiopharmaSegmentMember2024-06-300001121404country:FR2025-01-012025-06-300001121404country:FR2024-01-012024-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2025-01-012025-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2024-01-012024-06-300001121404country:CN2025-01-012025-06-300001121404country:CN2024-01-012024-06-300001121404sny:ReportableGeographicalZonesMember2025-01-012025-06-300001121404sny:ReportableGeographicalZonesMember2024-01-012024-06-300001121404srt:EuropeMember2025-06-300001121404srt:EuropeMember2024-12-310001121404country:FR2025-06-300001121404country:FR2024-12-310001121404country:US2025-06-300001121404country:US2024-12-310001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2025-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2024-12-310001121404country:CN2025-06-300001121404country:CN2024-12-310001121404sny:ReportableGeographicalZonesMember2025-06-300001121404sny:ReportableGeographicalZonesMember2024-12-310001121404sny:CertainWholesalersInTheUnitedStatesMember2025-01-012025-06-300001121404sny:CustomerOneMember2025-01-012025-06-300001121404sny:CustomerTwoMember2025-01-012025-06-300001121404sny:CustomerThreeMember2025-01-012025-06-300001121404sny:CustomerOneMember2024-01-012024-06-300001121404sny:CustomerTwoMember2024-01-012024-06-300001121404sny:CustomerThreeMember2024-01-012024-06-300001121404sny:OpellaBusinessMember2025-01-012025-06-300001121404sny:VicebioLtdMember2025-07-222025-07-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

Commission File Number: 001-31368

SANOFI

(Translation of registrant’s name into English)

46 avenue de la Grande Armée – 75017 Paris

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

In July 2025, Sanofi issued the financial statements and half year management report attached hereto as Exhibit 99.1 and 99.2 which are incorporated herein by reference.

Exhibit No.						Description
Exhibit 99.1			Condensed half-year consolidated financial statements for 2025
Exhibit 99.2			2025 Half-year management report, Statutory Auditors’ Report and Responsibility Statement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: July 31, 2025

SANOFI

By:

/s/ Alexandra Roger

Name:

Alexandra Roger

Title:

Head of Securities Law and Capital Markets

FAQ

What information is available?

This document appears to contain limited substantive content.